A Study Comparing Venous Thromboembolism (VTE)-Related Healthcare Resource Utilization And Costs Of Cancer Patients Treated With Anticoagulant Therapies.
Phase of Trial: Phase IV
Latest Information Update: 02 Feb 2017
At a glance
- Drugs Low molecular weight heparin (Primary) ; Rivaroxaban (Primary) ; Warfarin (Primary)
- Indications Venous thromboembolism
- Focus Therapeutic Use
- 02 Feb 2017 New trial record
- 06 Dec 2016 Results presented at the 58th Annual Meeting and Exposition of the American Society of Hematology.